国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

李氏大藥廠(chǎng)Lee's Pharm
李氏大藥廠(chǎng)控股有限公司（「李氏大藥廠(chǎng)」或「集團」）是一家已上市生物醫藥公司，于中國醫藥行業(yè)經(jīng)營(yíng)超過(guò)18年。集團擁有國際視野并結合已在中國建立了穩固的藥品發(fā)展、臨床發(fā)展、規管、制造及銷(xiāo)售以及市場(chǎng)推廣的業(yè)務(wù)模式，目前在中國推出市場(chǎng)的產(chǎn)品共有十一種。李氏大藥廠(chǎng)致力于不同范疇，包括心血管及傳染疾病、皮膚醫學(xué)、腫瘤學(xué)、婦科學(xué)等多個(gè)不同領(lǐng)域。而其它處于不同開(kāi)發(fā)階段產(chǎn)品亦有超過(guò)三十種，包括來(lái)自?xún)炔垦邪l(fā)及近期購買(mǎi)各美國, 歐洲公司及日本的特許及分銷(xiāo)權。于二零一零年，李氏大藥廠(chǎng)更獲亞洲財經(jīng)雜志《Finance Asia》頒發(fā)「2010亞洲最佳公司選舉 – (中國區)最佳小型企業(yè)」第二名。 于2011年9月李氏大藥廠(chǎng)獲福布斯選為亞洲最佳二百公司(營(yíng)業(yè)額少于十億美元)。 李氏大藥廠(chǎng)的目標是成為亞洲成功的生物醫藥集團，提供能治療疾病，同時(shí)改善身體及生活素質(zhì)。

李氏大藥廠(chǎng)的策略性股東，Sigma Tau Group是羅馬（意大利）國際領(lǐng)先的醫藥研究公司。Sigma Tau 進(jìn)行的研發(fā)活動(dòng)和商業(yè)技術(shù)與李氏大藥廠(chǎng)現時(shí)的業(yè)務(wù)有互補的作用，為李氏大藥廠(chǎng)帶來(lái)重要的業(yè)務(wù)協(xié)同效益。

Lee's Pharmaceutical Holdings Limited (Lee's Pharm or “the Group”) is a public biopharmaceutical company with over 18 years operation in China's pharmaceutical industry. It is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing in China with global perspectives and currently markets eleven products in the PRC. Lee's Pharm focuses on several different areas such as cardiovascular and infectious diseases, dermatology, oncology, gynecology and others. It has more than 30 products under different development stages stemming from both internal R&D as well as from the recent acquisition of licensing and distribution rights from various US, European and Japanese companies. In 2010, Lee’s Pharm ranked as Best Small-Cap Company in China (Rank 2nd) by Finance Asia. In September 2011, Lee's Pharm has been selected by Forbes as one of Asia's 200 Best Under A Billion Company (turnover less than US$1 billion). The mission of Lee's Pharm is to become a successful biopharmaceutical group in Asia providing innovative products to fight diseases and improve health and quality of life.
Sigma Tau Group, the leading research-based international pharmaceutical company based in Rome (Italy), is a strategic shareholder of Lee's Pharm. Sigma Tau's ongoing R&D activities and commercial know-how are complementary to the existing business activities of Lee's Pharm and will result in creating significant business synergies for Lee's Pharm.